A recent study indicates that individuals who come off blockbuster slimming jabs like Wegovy and Mounjaro can put back on reduced body mass at a significantly accelerated pace than those who halt traditional diet and exercise regimens.
Findings released in a leading health publication demonstrates that while obese individuals frequently drop about a fifth of their total mass while using the jabs, the weight is regained at an estimated rate of 0.8 kg per month upon discontinuation.
"Individuals using such medications need to be informed of the danger of rapid rebound weight gain when the treatment ends," stated researcher Dr. Susan Jebb.
That rate of regain means a return to original mass in about one and a half years.
Comparing Treatments
The research, which looked at 37 of studies involving thousands of patients, contrasted the results of the injectable medications with conventional dieting.
Scientists point out that individuals who shed pounds through diet and exercise generally see a slower weight regain—around 100 grams monthly—after stopping.
Understanding the Quick Rebound
Experts propose the way of the jabs explains the accelerated rebound.
These medications imitate a body's own chemical called glucagon-like peptide-1, which controls feelings of fullness.
"Sustained high doses of GLP-1 concentrations far above than the body's typical production may cause the body to generate a reduced amount of its own natural GLP-1, and could diminish responsiveness to its actions," explained Dr. Adam Collins, a dietetics expert.
"Withdrawal of this medication results in appetite is uncontrolled, making excessive eating far more likely."
A Chronic Condition?
Medical guidelines recommend the jabs for people with weight-linked health risks, accompanied by recommended diet and exercise modifications.
A number of clinicians say that, considering the high risk of relapse, the therapy might need to be long-term.
This view is supported by pharmaceutical companies, who say that the findings "underscore the chronic character of obesity," comparing it to managing diseases like diabetes.
Patient Testimonies
Users who have stopped the jabs explain a powerful resurgence of hunger.
"It felt as if something activating and you're instantly starving," recalled a patient.
The struggle is compounded if individuals have not established sustainable dietary or behavioural changes during therapy.
Growing Interest
Recent estimates suggest that millions of people in the UK have used these injections in the past year, with interest remaining high.
- Use is higher among women than men.
- The 40s and 50s demographic shows the highest level of interest.
- Many access the drugs through private prescriptions rather than public health services.
In conclusion, clinicians emphasize that while GLP-1 drugs are effective tools for weight loss, they are not a permanent cure and maintained weight loss relies on ongoing lifestyle management.
